Time to Anticoagulation Reversal and Outcomes After Intracerebral Hemorrhage

Kevin N. Sheth(Yale University), Jeffrey L. Saver(University of California, Los Angeles), Deepak L. Bhatt(Mount Sinai Hospital), Brooke Alhanti(Clinical Research Institute), Eric E. Smith(University of Calgary), Nicole Solomon(Clinical Research Institute), Ying Xian(Indianapolis Zoo), Ilya Danelich(AstraZeneca (United States)), Brian Mac Grory(Duke University), Joshua N. Goldstein(Massachusetts General Hospital), Jennifer Frontera(Norwegian Womens Public Health Association), Gregg C. Fonarow(UCLA Medical Center), Raymond Chuen‐Chung Chang(AstraZeneca (United States)), Lee H. Schwamm(Yale University), Steven R. Messé(Yale University), Joanna Huang(AstraZeneca (United States)), J. Claude Hemphill(University of California, San Francisco)
JAMA Neurology
February 9, 2024
10.1001/jamaneurol.2024.0221
Cited by 81

Related Papers

Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
|Stroke|2019|7.2k
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2018|6.3k
Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke
|New England Journal of Medicine|2015|6k
Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct
|New England Journal of Medicine|2017|5.5k
2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
|Stroke|2018|5.5k